Join us on The James Cancer-Free World Podcast as we talk to the top scientists and doctors at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). They’ll discuss – in easy-to-understand language – all the cutting-edge cancer research going on at Ohio State and how this is improving patient care and ultimately saving lives.
About the OSUCCC – James:
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of 51 National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet ® designation, the highest honor an organization can receive for quality patient care and professional nursing practice.
Episode 72: Advances in Precision Cancer Medicine at The James, with Sameek Roychowdhury
“If we can identify some of the tricks cancer is pulling to grow, travel or hide from the immune system, we can leverage that to flip the switch and help the immune system find the cancer cells, Sameek Roychowdhury, MD, PhD, says while discussing precision cancer medicine. “This is not a new idea.”
Episode 71: Breast Cancer Myths, with Doreen Agnese, MD, & Sagar Sardesai, MBBS
“I believe there are so many myths surrounding breast cancer because there is so much fear and uncertainty surrounding a diagnosis,” Sardesai said. In this episode, Sardesai and Agnese help us debunk several common breast cancer myths such as: Nobody in my family has had breast cancer, so I’m not at risk; I don’t feel a lump, so I can’t have breast cancer; Only older women get breast cancer. These myths are dangerous as they can prevent women from doing regular self-exams, getting mammography screenings, and from being diagnosed in the early stages of breast cancer.
Episode 70: Overcoming the Cancer Healthcare Disparity Problem, with Chasity Washington
The black lives matter movement, quest for social justice and the COVID-19 pandemic have combined to expose many of the inequities in the nation’s healthcare system, and how this impacts poor and minority populations, especially African Americans. In this episode of the James Cancer-Free World, Chasity Washington, Director of the OSUCCC – James Center for Cancer Health Equity, explains how the history of racism, and explicit and implicit bias combine to impact minorities and create health disparities. Washington also describes several Center for Cancer Health Equity programs, including a mobile mammography unit, a cervical cancer outreach program, and a free, yearly colorectal cancer screening program that have combined to help bring these live-saving screening programs to underserved populations in Columbus and throughout Ohio and can serve as national models. The center will soon launch a mobile lung cancer screening unit to underserved areas.
Episode 69: Ovarian Cancer Treatment Advances & Genetics, With Dave O'Malley & Leigha Senter
“We used to call ovarian cancer the disease that whispers and now we say, let’s break that silence,” said David O’Malley, MD, director of the OSUCCC – James Division of Gynecologic Cancer. In Episode 69 of the James Cancer-Free World Podcast, O’Malley and Leigha Senter, an OSUCCC – James genetics counselor, help break the silence and talk about advances in the treatment of this type of cancer, and how more widespread genetic testing will save lives. O'Malley said their have been great advances in the past 10 years and now ovarian cancer can be treated as a chronic disease in more and more cases. Gentic testing of patients with ovarian cancer, Senter explained, can determine who has BRCA, an inherited genetic mutations that increases a woman's risk for breast cancer - and ovarian cancer, which is harder to detect than breast cancer and often presents in the later stages.
Episode 68: The Stage IV Cancer Bill & Drug Repository Program, with Jennifer Carlson
Good public policy helps push the needle forward for research and treatment, and also helps make cancer treatment more accessible to everyone, especially underserved populations that struggle to get access to good healthcare. In this episode, Jennifer Carlson, the James associate vice president for External Relations and Advocacy in the Office of Health Sciences, discusses the Stage IV Bill that aims to do away with "fail first" treatments, and the new James cancer drug repository program. "That's what drives me," she says. "The progress we've made and what we can offer our patients through better public policy."
Episode 67: Preventing, Detecting & Treating Skin Cancer, with Carlo Contreras, MD
“Any type of skin cancer not properly treated can become aggressive and can be problematic,” says Carlo Contreras, MD, a James surgical oncologist specializing in skin cancer. In this episode, Contreras discusses the different types of skin cancer, including basal and squamous cell, the two most common and treatable forms of skin cancer, as well as the more rare and aggressive melanoma and Merkel cell carcinomas.